Perlecan: Roles in osteoarthritis and potential treating target

Xiaoxuan Zhao(Dalian Dermatosis Hospital), Yusheng Li(Central South University), Heng-Zhen Li(Jinan University), Shinen Naranmandakh(National University of Mongolia), Wenfeng Xiao(Central South University), Wenqing Xie(Chinese Academy of Sciences), Jean‐Yves Reginster(University of Liège), Olivier Bruyère(University of Liège)

Life Sciences

November 12, 2022

10.1016/j.lfs.2022.121190

Cited by 10

Related Papers

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)

|Endocrine|2017|68

Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family

|Military Medical Research|2024|36

OPN inhibits autophagy through CD44, integrin and the MAPK pathway in osteoarthritic chondrocytes

|Frontiers in Endocrinology|2022|20

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach

|Aging Clinical and Experimental Research|2022|16

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway

|Stem Cell Research & Therapy|2023|9